glp 1 and aging Effects of Glucagon-like Peptide-1 Receptor Agonists on Skin Homeostasis Skin Processes GLP-1 programs the neurovascular landscape:

Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 17 randomised controlled trials

Bakalov 2020), skin rash (NatMed 2025, unclear, unknown grading), hypophosphatemia resolved after discontinuation (NatMed2025)

In this study, we identified a previously undescribed role for lactate as an alternative carbon source in detached breast cancer cells, maintaining MIC stemness

Weight regain is very common after stopping a GLP-1on average, up to two-thirds of the lost weight is regained within one year

Update on Copay for GLP-1 Medications